Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits

SIMPLE SUMMARY: Oncolytic viruses can be a potent tool in the fight against cancer. However, in clinical settings their ability to replicate in and kill tumors is often limited. Combinations with specific small molecule compounds can address some of these limitations and help oncolytic viruses reach...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiesschaert, Bart, Angerer, Katharina, Park, John, Wollmann, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306439/
https://www.ncbi.nlm.nih.gov/pubmed/34298601
http://dx.doi.org/10.3390/cancers13143386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306439/
https://www.ncbi.nlm.nih.gov/pubmed/34298601
http://dx.doi.org/10.3390/cancers13143386

Ejemplares similares